Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Sep. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| John Doherty [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On August 6, 2026, John Doherty, our Executive Vice President, Chief Financial Officer, adopted a "Rule 10b5-1 trading arrangement" (as such term is defined in Item 408 of Regulation S-K) (a "10b5-1 Plan"), pursuant to which Mr. Doherty has authorized the sale of up to 200,000 shares of our Class A common stock during a period beginning on November 4, 2026, and ending on September 15, 2027. This 10b5-1 Plan was entered into in accordance with the Company’s policies regarding transactions in our securities.
|
| Name | John Doherty |
| Title | our Executive Vice President, Chief Financial Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | August 6, 2026 |
| Expiration Date | September 15, 2027 |
| Arrangement Duration | 315 days |
| Aggregate Available | 200,000 |
| Dr. Jonathan Rothberg [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On August 14, 2026, Dr. Jonathan Rothberg, a member of our board of directors, acting on his own and on behalf of 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC, and Dr. Bonnie Rothberg, Dr. Jonathan Rothberg's spouse, adopted a 10b5-1 Plan, pursuant to which Dr. Jonathan Rothberg has authorized the sale of up to 363,348 shares of our Class A common stock and up to 8,049,929 shares of our Class B common stock during a period beginning on November 12, 2026, and ending on November 12, 2027. Any shares of Class B common stock sold pursuant to this 10b5-1 Plan will automatically convert into shares of Class A common stock on a one-to-one basis upon sale. This 10b5-1 Plan was entered into in accordance with the Company’s policies regarding transactions in our securities.
|
| Name | Dr. Jonathan Rothberg |
| Title | a member of our board of directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | August 14, 2026 |
| Expiration Date | November 12, 2027 |
| Arrangement Duration | 365 days |
| Nicholas Caezza [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On August 19, 2026, Nicholas Caezza, our Vice President, Deputy General Counsel and Corporate Secretary, adopted a 10b5-1 Plan, pursuant to which Mr. Caezza has authorized the sale of up to 15,000 shares of our Class A common stock during a period beginning on January 4, 2027, and ending on October 29, 2027. This 10b5-1 Plan was entered into in accordance with the Company’s policies regarding transactions in our securities.
|
| Name | Nicholas Caezza |
| Title | our Vice President, Deputy General Counsel and Corporate Secretary |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | August 19, 2026 |
| Expiration Date | October 29, 2027 |
| Arrangement Duration | 298 days |
| Aggregate Available | 15,000 |
| Dr. Jonathan Rothberg Trading Arrangement, Class A Common Stock [Member] | Dr. Jonathan Rothberg [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 363,348 |
| Dr. Jonathan Rothberg Trading Arrangement, Class B Common Stock [Member] | Dr. Jonathan Rothberg [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 8,049,929 |